--- title: "Kintor Pharmaceutical (9939) stock and investor profile" url: "https://aibio.space/companies/kintor-pharmaceutical/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Kintor Pharmaceutical Ltd (HKEX: 9939), China. The directory classifies it as Biotechnology. Listing facts, related biotech companies and news on aibio.space." --- 9939 Kintor Pharmaceutical Ltd HKEX · China # Kintor Pharmaceutical (9939) news Kintor Pharmaceutical Ltd is a public biotech or pharmaceutical company listed on HKEX under the ticker 9939, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Kintor Pharmaceutical news We have not published a story on Kintor Pharmaceutical yet. When there is news, it will appear here. ## Kintor Pharmaceutical at a glance - **Ticker**: 9939 - **Listing**: HKEX - **Country**: China ### Related companies - [Daan Gene Co.](https://aibio.space/companies/daan-gene/) SZSE: 002030 - [Jacobio Pharmaceuticals Group Co.](https://aibio.space/companies/jacobio-pharmaceuticals/) HKEX: 1167 - [Chongqing Zhifei Biological Products Co.](https://aibio.space/companies/chongqing-zhifei-biological-products/) SZSE: 300122 - [Hangzhou Tigermed Consulting Co.](https://aibio.space/companies/hangzhou-tigermed-consulting/) SZSE: 300347 - [Frontier Biotechnologies](https://aibio.space/companies/frontier-biotechnologies/) SSE: 688221 - [PegBio Co.](https://aibio.space/companies/pegbio/) HKEX: 2565 - [Hubei Goto Biopharm Group Co.](https://aibio.space/companies/hubei-goto-biopharm/) SZSE: 300966 - [Xiamen Amoytop Biotech Co.](https://aibio.space/companies/xiamen-amoytop-biotech/) SSE: 688278 ### Also on HKEX - [Alphamab Oncology](https://aibio.space/companies/alphamab-oncology/) 9966 - [China Shineway Pharmaceutical Group](https://aibio.space/companies/china-shineway-pharmaceutical/) 2877 - [Pak Fah Yeow International](https://aibio.space/companies/pak-fah-yeow-international/) 239 - [Sino Biopharmaceutical](https://aibio.space/companies/sino-biopharmaceutical/) 1177 - [BioDlink International Company](https://aibio.space/companies/biodlink-international/) 1875 - [Extrawell Pharmaceutical Holdings](https://aibio.space/companies/extrawell-pharmaceutical/) 858 ## Questions about Kintor Pharmaceutical What is the ticker symbol of Kintor Pharmaceutical? Kintor Pharmaceutical Ltd trades under the ticker 9939 on HKEX. Where is Kintor Pharmaceutical listed? Kintor Pharmaceutical Ltd is listed on HKEX. Which country or territory is Kintor Pharmaceutical listed under? Our directory records Kintor Pharmaceutical Ltd under China. What does Kintor Pharmaceutical do? Our directory classifies Kintor Pharmaceutical Ltd as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Kintor Pharmaceutical? The ISIN recorded for Kintor Pharmaceutical Ltd is KYG5273B1077. Does aibio.space cover Kintor Pharmaceutical? aibio.space lists Kintor Pharmaceutical Ltd among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Kintor Pharmaceutical? Companies in our directory listed in the same country and business area as Kintor Pharmaceutical: Daan Gene Co., Jacobio Pharmaceuticals Group Co., Chongqing Zhifei Biological Products Co., Hangzhou Tigermed Consulting Co., Frontier Biotechnologies, PegBio Co.. ## Investor discussion: Kintor Pharmaceutical Members talk about Kintor Pharmaceutical (9939). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Kintor Pharmaceutical, newest first. Each line links the filing it comes from. 1. 2025-11-21 Financings Share or debt issue: COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1121/2025112101299.pdf) 2. 2025-11-12 Financings Share or debt issue: SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1112/2025111201518.pdf) 3. 2025-08-14 Financings Share or debt issue: COMPLETION OF TOP-UP PLACING OF EXISTING SHARES AND SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0814/2025081401446.pdf) 4. 2025-07-31 Financings Share or debt issue: (1) TOP-UP PLACING OF EXISTING SHARES AND (2) SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0801/2025080100013.pdf) ## Press releases Headlines of Kintor Pharmaceutical's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-21 HKEXnews [VOLUNTARY ANNOUNCEMENT - RECEIPT OF NOTICE OF GRANT OF INVENTION PATENT FOR KT-939](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1021/2026102100981.pdf) 2. 2026-09-21 HKEXnews [RESIGNATION OF CHIEF FINANCIAL OFFICER, JOINT COMPANY SECRETARY AND PROCESS AGENT, APPOINTMENT OF CHIEF FINANCIAL OFFICER AND APPOINTMENT OF PROCESS AGENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0921/2026092100800.pdf) 3. 2026-09-06 HKEXnews [VOLUNTARY ANNOUNCEMENT - SUCCESSFUL COMPLETION OF LONG-TERM HUMAN SAFETY TRIAL OF KT-939](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0907/2026090700007.pdf) 4. 2026-08-19 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0819/2026081901703.pdf) 5. 2026-07-31 HKEXnews [UPDATE ON MEASURES AND ACTIONS TAKEN IN RESOLVING THE DISCLAIMER OF OPINION IN THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0731/2026073102051.pdf) 6. 2026-06-18 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, 18 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0618/2026061800510.pdf) 7. 2026-06-10 HKEXnews [VOLUNTARY ANNOUNCEMENT - POSITIVE INTERIM RESULT IN LONG-TERM HUMAN SAFETY TRIAL OF KT-939 AND COMMENCING OF REGISTRATION APPLICATION FOR THE NEW RAW MATERIAL](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0610/2026061001312.pdf) 8. 2026-05-31 HKEXnews [VOLUNTARY ANNOUNCEMENT - KX-826 PHASE III CLINICAL TRIAL AND COMBINATION THERAPY STUDY DATA FOR AGA PRESENTED AT THE 2026 WORLD CONGRESS FOR HAIR RESEARCH (WCHR 2026), AND WAS SELECTED AS AN OUTSTANDING POSTER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0601/2026060100009.pdf) 9. 2026-05-28 HKEXnews [VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY CHAIRMAN OF THE BOARD, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER DR.YOUZHI TONG BY 2,512,500 SHARES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0528/2026052801979.pdf) 10. 2026-05-26 HKEXnews [RETIREMENT OF AUDITOR AND PROPOSED APPOINTMENT OF NEW AUDITOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0526/2026052602018.pdf) 11. 2026-05-26 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0526/2026052601924.pdf) 12. 2026-04-20 HKEXnews [VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0420/2026042001474.pdf) 13. 2026-03-30 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0330/2026033004368.pdf) 14. 2026-03-18 HKEXnews [VOLUNTARY ANNOUNCEMENT - PHASE III STAGE OF PIVOTAL CLINICAL TRIAL OF KX-826 TINCTURE 1.0% FOR THE TREATMENT OF MALE ADULT AGA IN CHINA REACHED PRIMARY ENDPOINT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0318/2026031801532.pdf) 15. 2026-03-17 HKEXnews [VOLUNTARY ANNOUNCEMENT - STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH CHICMAX IN RELATION TO KT-939](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0317/2026031701470.pdf) 16. 2026-03-12 HKEXnews [VOLUNTARY ANNOUNCEMENT - STRATEGIC COOPERATION AGREEMENT WITH FONOW MEDICINE IN RELATION TO KT-939](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0312/2026031201196.pdf) 17. 2026-02-12 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE VOLUNTARY ANNOUNCEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0212/2026021200514.pdf) 18. 2026-01-26 HKEXnews [VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY CHAIRMAN OF THE BOARD, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER DR.YOUZHI TONG BY 4,700,000 SHARES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0126/2026012600909.pdf) 19. 2026-01-21 HKEXnews [VOLUNTARY ANNOUNCEMENT - EXCLUSIVE SALES AGENCY AGREEMENT IN RELATION TO ANTI-HAIR LOSS FOAM PRODUCT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0121/2026012100426.pdf) 20. 2025-12-11 HKEXnews [(1) RESIGNATION OF NON-EXECUTIVE DIRECTOR; AND (2) APPOINTMENT OF NON-EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1211/2025121100620.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:9939 on TradingView](https://www.tradingview.com/symbols/HKEX-9939/). ## Listing details Kintor Pharmaceutical Ltd is a public biotech or pharmaceutical company listed on HKEX under the ticker 9939, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Kintor Pharmaceutical Ltd - **Ticker**: 9939 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Biotechnology - **ISIN**: KYG5273B1077 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-9939/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/kintor-pharmaceutical/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Kintor Pharmaceutical (9939) stock and investor profile", 2026-10-31, https://aibio.space/companies/kintor-pharmaceutical/